Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples